Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-030211

President and CEO sold 25,000 shares at $56.19 ($1,404,805)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Campbell David Alan · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-24 Sale : show line 1 in the form 10b5-1 −25,000 $56.19 $1,404,805 217,054 D
Open-market sales · 25,000 sh · avg $56.19 · $1,404,805
Loading xslF345X05/form4-12272024_081201.xml…